ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Announces Second Grant Cycle For 1995

April 28, 1995

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980

Creating the Modern Cancer Center

November 2, 2021

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

In Brief: NCI To File Heroin IND For Pain Control; Sen. Cranston To Keynote Meeting On Centers

March 31, 1978

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997